Market Cap

Ascentage Pharma Group International Market Capitalization:

HK$8.59 Billion

HKD as of July 1, 2024

US$1.10 Billion

business Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Main Stock Listing

HKEX: 6855

Market Capitalization History of Ascentage Pharma Group International

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Ascentage Pharma Group International market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$7.67 B -1.61%
Jan. 1, 2023 HK$7.79 B 35.07%
Jan. 1, 2022 HK$5.77 B -51.62%
Jan. 1, 2021 HK$11.92 B 55.33%
Jan. 1, 2020 HK$7.68 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Ascentage Pharma Group International Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Ascentage Pharma Group International has the following listings and related stock indices.


Stock: HKEX: 6855

Stock: FSX: 36X

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.